Phenex Pharmaceuticals

About:

Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.

Website: https://www.phenex-pharma.com

Twitter/X: phenexpharma

Top Investors: KfW, LBBW VC, Creathor Ventures, CD-Venture, COI Partners

Description:

Phenex Pharmaceuticals AG was founded in 2002. It is a privately held drug discovery & development company based in the Biotech Cluster Rhine-Neckar with Biology and Chemistry laboratories and offices primarily in Heidelberg and partly in Ludwigshafen. Their company focuses its small-molecule drug discovery expertise in Liver and Gastrointestinal disease areas and has now recently entered the field of Cancer Therapy. They not only devise novel therapeutics for known targets but additionally aim to identify novel molecular mechanisms. This provides the basis for the identification of novel small molecules with "game changing" capabilities. Historically, Phenex has identified two of such novel mechanisms from literature and has translated them into proprietary novel therapeutic small molecules.

Total Funding Amount:

24.8M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Heidelberg, Baden-Wurttemberg, Germany

Founded Date:

2002-01-01

Contact Email:

info(AT)phenex-pharma.com

Founders:

Claus Kremoser

Number of Employees:

11-50

Last Funding Date:

2012-10-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai